Add like
Add dislike
Add to saved papers

SERCA2a directs the cardioprotective role of nano-emulsion curcumin against PM 2.5 -induced cardiac injury in rats by prohibiting PERK-eIF2α pathway.

Life Sciences 2022 November 13
AIMS: Activation of endoplasmic reticulum stress (ERS) by particulate matter 2.5 (PM2.5 ) has recently been linked to an increased risk of heart problems. Although the PERK- eIF2α pathway is known to be involved in ERS, its crucial role in the pathogenesis of PM2.5 -induced cardiotoxicity remains unclear. With the expected potentiality of SERCA2a to modulate ERS via inhibiting the PERK-eIF2α axis, this study intended to assess the possible cardioprotective efficacy of nano-emulsion curcumin (NEC), as a SERCA2a activator, against PM2.5 -induced heart damage.

MAIN METHODS: Thirty rats were specified into: Vehicle (V); Blank Filter (BF); NEC; PM and NEC + PM. Cardiac biomarkers as PTX3 and cTnI were assayed. The oxidant/antioxidant status was evaluated via detecting Nrf2/HO-1 axis, as well as MDA and TAC. In addition, the protein expressions of PLN, DWORF, SERCA2a, PERK/eIF2α/ATF4/CHOP, and PI3K/AKT/mTOR in the heart were assessed by western blotting. The levels of inflammatory cytokines (TNF-α and IL-1β) and apoptotic markers were also determined. For detecting PM and NEC particles, cardiac tissues were examined using TEM.

KEY FINDINGS: The results revealed that NEC markedly alleviated the oxidative stress following PM2.5 exposure, up-regulated DWORF, and produced a significant improvement in cardiac functions. Through activating SERCA2a, NEC could hinder ERS, ameliorate PM2.5 -associated cardiac inflammation and myocardial apoptosis by suppressing Bax/Bcl-2 ratio and caspase-3 expression, as well as inhibiting autophagy.

SIGNIFICANCE: These findings revealed that NEC may have a SERCA2a-dependent cardioprotective effect against PM2.5 -induced cardiac injury via inhibiting the PERK-eIF2 pathway.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app